Takeda Pharmaceutical Co: Under Agreement Ascentage Pharma to Receive Option Payment of $100 Mln Upon Signing of Exclusive Option to License Agreement
武田製藥公司:與安普生製藥簽署排他性許可協議後,將獲得1億美元的選擇權支付。
Takeda Pharmaceutical Co: Under Agreement Ascentage Pharma to Receive Option Payment of $100 Mln Upon Signing of Exclusive Option to License Agreement
武田製藥公司:與安普生製藥簽署排他性許可協議後,將獲得1億美元的選擇權支付。
譯文內容由第三人軟體翻譯。